Arlyn W. Kinkel

1.1k total citations
27 papers, 794 citations indexed

About

Arlyn W. Kinkel is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Analytical Chemistry. According to data from OpenAlex, Arlyn W. Kinkel has authored 27 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Analytical Chemistry. Recurrent topics in Arlyn W. Kinkel's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Analytical Methods in Pharmaceuticals (7 papers) and Pharmaceutical studies and practices (5 papers). Arlyn W. Kinkel is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Analytical Methods in Pharmaceuticals (7 papers) and Pharmaceutical studies and practices (5 papers). Arlyn W. Kinkel collaborates with scholars based in United States, China and Israel. Arlyn W. Kinkel's co-authors include Armando J. Aguiar, Joseph C. Samyn, R. A. Buchanan, Edward J. Randinitis, Allen J. Sedman, J. R. Goulet, Anthony J. Glazko, Luis Miguel Molina Fernández, Jerome J. Schentag and R W Schultz and has published in prestigious journals such as Neurology, Antimicrobial Agents and Chemotherapy and Clinical Chemistry.

In The Last Decade

Arlyn W. Kinkel

27 papers receiving 670 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arlyn W. Kinkel United States	14	187	185	176	154	113	27	794
Arzu Selen United States	18	200 1.1×	238 1.3×	253 1.4×	82 0.5×	77 0.7×	30	931
Robert E. Notari United States	19	151 0.8×	118 0.6×	249 1.4×	147 1.0×	159 1.4×	66	1.4k
Gerald J. Yakatan United States	16	66 0.4×	101 0.5×	151 0.9×	70 0.5×	179 1.6×	50	997
D.G. Perrier United States	21	208 1.1×	101 0.5×	223 1.3×	59 0.4×	83 0.7×	45	1.3k
Theodore R. Bates United States	22	616 3.3×	158 0.9×	184 1.0×	207 1.3×	209 1.8×	53	1.4k
André J. Jackson United States	19	106 0.6×	142 0.8×	165 0.9×	22 0.1×	79 0.7×	46	800
F. Douglas Boudinot United States	26	83 0.4×	188 1.0×	314 1.8×	153 1.0×	114 1.0×	97	2.1k
J. Godbillon Switzerland	24	222 1.2×	181 1.0×	286 1.6×	32 0.2×	376 3.3×	61	1.3k
Robert A. Carr United States	19	338 1.8×	70 0.4×	92 0.5×	156 1.0×	79 0.7×	41	986
Nobutoshi Watari Japan	14	156 0.8×	66 0.4×	78 0.4×	102 0.7×	56 0.5×	36	516

Countries citing papers authored by Arlyn W. Kinkel

Since Specialization

Citations

This map shows the geographic impact of Arlyn W. Kinkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arlyn W. Kinkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arlyn W. Kinkel more than expected).

Fields of papers citing papers by Arlyn W. Kinkel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arlyn W. Kinkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arlyn W. Kinkel. The network helps show where Arlyn W. Kinkel may publish in the future.

Co-authorship network of co-authors of Arlyn W. Kinkel

This figure shows the co-authorship network connecting the top 25 collaborators of Arlyn W. Kinkel. A scholar is included among the top collaborators of Arlyn W. Kinkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arlyn W. Kinkel. Arlyn W. Kinkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Randinitis, Edward J., R. A. Buchanan, & Arlyn W. Kinkel. (1990). Pharmacokinetic Profile of a 300‐mg Extended Phenytoin Sodium Capsule (Dilantin) Formulation. Epilepsia. 31(4). 458–464. 5 indexed citations

Koup, Jeffrey R., et al.. (1990). A single and multiple dose pharmacokinetic and metabolism study of meclofenamate sodium. Biopharmaceutics & Drug Disposition. 11(1). 1–15. 10 indexed citations

Randinitis, Edward J., Allen J. Sedman, Peter G. Welling, & Arlyn W. Kinkel. (1989). Effect of a High‐Fat Meal on the Bioavailability of a Polymer‐Coated Erythromycin Particle Tablet Formulation. The Journal of Clinical Pharmacology. 29(1). 79–84. 9 indexed citations

Grasela, Thaddeus H., Jerome J. Schentag, Allen J. Sedman, et al.. (1989). Inhibition of enoxacin absorption by antacids or ranitidine. Antimicrobial Agents and Chemotherapy. 33(5). 615–617. 85 indexed citations

Nix, David E., R W Schultz, R. Wayne Frost, et al.. (1988). The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin. Journal of Antimicrobial Chemotherapy. 21(suppl B). 87–95. 14 indexed citations

Koup, Jeffrey R., et al.. (1988). Plasma and synovial fluid meclofenamic acid concentrations in patients with rheumatoid arthritis of the knee. European Journal of Clinical Pharmacology. 35(2). 199–202. 5 indexed citations

Toothaker, Roger D., et al.. (1987). The Influence of Food on the Oral Absorption of Bevantolol. The Journal of Clinical Pharmacology. 27(4). 297–299. 7 indexed citations

Randinitis, Edward J., et al.. (1986). Liquid chromatographic determination of gemfibrozil and its metabolite in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 383(2). 444–448. 17 indexed citations

Randinitis, Edward J., et al.. (1984). Gas chromatographic determination of gemfibrozil and its metabolites in plasma and urine. Journal of Chromatography B Biomedical Sciences and Applications. 307(1). 210–215. 25 indexed citations

10.

Buchanan, R. A., Arlyn W. Kinkel, Charles A. Alford, & Richard J. Whitley. (1980). Plasma levels and urinary excretion of vidarabine after repeated dosing. Clinical Pharmacology & Therapeutics. 27(5). 690–696. 21 indexed citations

11.

Smith, Thomas C. & Arlyn W. Kinkel. (1976). Absorption and metabolism of phenytoin from tablets and capsules. Clinical Pharmacology & Therapeutics. 20(6). 738–742. 6 indexed citations

12.

Buchanan, R. A., et al.. (1976). Ethosuximide dosage regimens. Clinical Pharmacology & Therapeutics. 19(2). 143–147. 6 indexed citations

13.

Goulet, J. R., Arlyn W. Kinkel, & T. C. Smith. (1976). Metabolism of ethosuximide. Clinical Pharmacology & Therapeutics. 20(2). 213–218. 15 indexed citations

14.

Kostenbauder, H.B., Robert P. Rapp, J. Patrick McGovren, et al.. (1975). Bioavailability and single‐dose pharmacokinetics of intramuscular phenytoin. Clinical Pharmacology & Therapeutics. 18(4). 449–456. 54 indexed citations

15.

Buchanan, R. A., et al.. (1974). Pyrvinium pamoate. Clinical Pharmacology & Therapeutics. 16(4). 716–719. 9 indexed citations

16.

Buchanan, R. A., et al.. (1973). The absorption and excretion of ethosuximide.. PubMed. 7(2). 213–8. 26 indexed citations

17.

Buchanan, R. A., Luis Miguel Molina Fernández, & Arlyn W. Kinkel. (1969). Absorption and Elimination of Ethosuximide In Children. PubMed. 9(6). 393–398. 38 indexed citations

18.

Glazko, Anthony J., et al.. (1968). An evaluation of the absorption characteristics of different chloramphenicol preparations in normal human subjects. Clinical Pharmacology & Therapeutics. 9(4). 472–483. 55 indexed citations

19.

Aguiar, Armando J., et al.. (1967). Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate. Journal of Pharmaceutical Sciences. 56(7). 847–853. 207 indexed citations

20.

Aguiar, Armando J., et al.. (1967). Deaggregation behavior of a relatively insoluble substituted benzoic acid and its sodium salt. Journal of Pharmaceutical Sciences. 56(10). 1243–1252. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact